Positions 51–62 of 62.
T2D is not what most of this community thinks it is — with the reasoning, because a rule without a reason gets ignored. The diabetes and obesity programmes are…
Posting this as a discussion rather than a claim: unpopular opinion: most of what gets said here about T2D is guesswork. Sensor accuracy varies across wear, and…
Check-in as promised in the title: anyone else notice hypoglycaemia kicking in around week 8. On hypoglycaemia, because the risk gets attributed to the wrong thing…
Asking properly rather than in a comment on somebody else’s thread: am I the only one who found hypoglycaemia harder than the injections. Sensor accuracy varies across…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsthe T2D rule is doing its job and people should stop complaining. Nothing about this affects the ranking maths, before anyone asks. Assumed the weight endpoints from…
The title is the argument: tried metformin for 12 weeks. here is what happened. Here is the rest of it. To save the first four comments: 12 weeks. The diabetes and…
Thinking out loud about this: we are measuring T2D at the wrong time and calling it noise. Assumed the weight endpoints from the obesity trials applied to my situation.…
13 months in and CGM is still the thing I get wrong, and the part I actually want to talk about is at the bottom. Pulling the figures out of the title: 13 months. All…
unpopular opinion: most of what gets said here about CGM is guesswork. I have gone back and forth on this for months. The three numbers, and what each one can and…
the A1c advice in here is 2 years out of date. Making the case below, and I expect to lose some of it in the comments. To save the first four comments: 2 years.…
5 months in and metformin is still the thing I get wrong. This is a description of what happened to me and not a plan for anybody else. Numbers, in the order they…
the A1c question that gets asked weekly, answered properly. Not a hot take, just something I have not seen said plainly here. Continuous monitoring shows the shape:…
Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference